VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy
NCT00210327
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma, Mucosa-Associated Lymphoid Tissue
Interventions
DRUG:
Bortezomib (drug)
Sponsor
International Extranodal Lymphoma Study Group (IELSG)